OLK OLINK HLDG AB

Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024

Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024

UPPSALA, Sweden, April 19, 2024 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 19 April 2024 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website,

Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability

The AGM adopted the Company’s income statement and balance sheet and the consolidated income statement and consolidated balance sheet.

The AGM resolved to dispose the Company's results in accordance with the Board of Directors’ proposal, whereby no dividend will be paid for the financial year 2023 and that the Company's available funds be capitalized in a new account.

The AGM also discharged the Board Members and the CEO from liability for the financial year 2023.

Remuneration to the Board of Directors and Auditor

The AGM decided, in accordance with the Nomination Committee’s proposal, that the remuneration to the Board of Directors shall be distributed as follows: USD 120,000 to the Chair of the Board of Directors, USD 70,000 to each of the other Board Members appointed by the AGM who are not employed by the Company, additionally USD 20,000 to the Chair of the Remuneration Committee and additionally USD 10,000 to each other member of the Remuneration Committee, additionally USD 30,000 to the Chair of the Audit Committee and additionally USD 15,000 to each other member of the Audit Committee. Tommi Unkuri shall not receive any fees for Board or Committee work. Total fees amount to USD 640,000.

The AGM decided that remuneration to the Auditor shall be paid according to approved invoices.

Election of board members

The AGM resolved, in accordance with the Nomination Committee’s proposal, that the Board of Directors shall consist of nine Board Members and one Deputy Board Member. For the period until the end of the next Annual General Meeting the AGM re-elected the present Board Members Jon Hindar, Jon Heimer, Solange Bullukian, Johan Lund, Nicolas Roelofs, Mary Reumuth, Robert Schueren, Dr. Gregory J. Moore and Tommi Unkuri. Furthermore, it was resolved to re-elect Jon Hindar as Chair of the Board of Directors.

The AGM resolved, in accordance with the Nomination Committee’s proposal, to re-elect Johan Pietilä Holmner as Deputy Board Member.

Election of auditor

The AGM resolved, in accordance with the Nomination Committee’s proposal, to elect the registered audit firm Ernst & Young AB as auditor for the period until the end of the next Annual General Meeting. Ernst & Young AB has informed that Fredrik Norrman will be appointed as auditor in charge.

Resolution on incentive program LTI I 2024 and issue of warrants and restricted stock units

The AGM resolved not to approve the Majority Shareholders’ proposal to adopt an additional Long Term Incentive program for the Board Members of the Company (“LTI I 2024”).

Resolution on incentive program LTI II 2024 and issue of warrants and restricted stock units

The AGM resolved, in accordance with the Board of Directors’ proposal, to adopt an additional Long Term Incentive program for the members of the group management, key employees, other employees and consultants of the Company and within the group (“LTI II 2024”).

LTI II 2024 consists of restricted stock units (with warrants as hedging arrangement). Upon exercise of all warrants issued within the frame of LTI II 2024 up to 849,195 shares (with reservation for any re-calculation) may be issued, equivalent to a maximum dilution of approximately 0.68 percent of the shares and votes of the Company. Upon full exercise of the warrants, the Company’s share capital will increase with SEK 2,065,162.94.

The calculations above have been based on the number of shares and votes in the Company as of the date of the notice.

Authorization for the Board of Directors to decide on a new issue

The AGM resolved, in accordance with the Board of Directors’ proposal, to authorize the Board of Directors, on one or several occasions until the next Annual General Meeting to resolve on issues of new shares, and that such new issue can be performed with deviation from the shareholders’ preferential rights. The authorization may only be utilized to the extent that it corresponds to a dilution of not more than 20 percent of the total number of shares based on the number of shares outstanding at the time of the 2024 Annual General Meeting. Payment shall be able to be made in cash, in kind, by offset or otherwise in accordance with other conditions.

For more information please contact:

IR Contact

David Deuchler, CFA

Gilmartin Group

Media Contact

Michael B. Gonzales

VP Global Marketing

Mobile: 7



EN
19/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OLINK HLDG AB

 PRESS RELEASE

Report from the Annual General Meeting of Olink Holding AB (publ) on 1...

Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024 UPPSALA, Sweden, April 19, 2024 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 19 April 2024 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, Adoption of the balance sheet and income statement, dispo...

 PRESS RELEASE

Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding B...

Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease UPPSALA, Sweden, April 02, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of an open access data library consisting of over 300,000 protein-disease risk associations, giving researchers a powerful new tool for revealing the biological mechanisms underlying 106 human diseases. In April 2023, the UK Biobank Pharma Proteomics Project (UKB-PPP) released data produced from over 50,000 samples analyzed using the Olink® Explore pl...

 PRESS RELEASE

Olink reports fourth quarter and full year 2023 financial results

Olink reports fourth quarter and full year 2023 financial results UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023. Highlights Fourth quarter 2023 revenue totaled $68.6 million, representing year over year growth of 18% on a reported basis and 17% on a constant currency adjusted like-for-like basisFull year revenue 2023 revenue totaled $169.6 million, achieving year over year growth of 21% on a reported basis and 21% on a constant currency adj...

 PRESS RELEASE

Olink publishes 2023 annual report

Olink publishes 2023 annual report UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2023 is now available on the Company’s website at . About OlinkOlink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and acade...

 PRESS RELEASE

Notice to attend the Annual General Meeting of Olink Holding AB (publ)

Notice to attend the Annual General Meeting of Olink Holding AB (publ) UPPSALA, Sweden, March 15, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual General Meeting to be held at 4:00 p.m. CET on Friday the 19 April 2024, in the Company’s facilities at Salagatan 16A, Uppsala. Registration for the meeting commences at 3:30 p.m. CET. NOTICE OF PARTICIPATION Shareholders who wish to attend in the proceedings of the Annual General Meeting must: be entered in the share regi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch